StartUp Health Raises $31M From Novartis, Ping An Group, Chiesi Group, GuideWell and Otsuka

startuphealth_cap-raise

StartUp Health Closes Second Fund to Invest in Companies Focused on Health Moonshots

StartUp Health, a global organization dedicated to investing in entrepreneurs working to achieve health moonshots, announced today that it has closed its second fund, raising $31M. Investors include Novartis, Ping An Group, Chiesi Group, GuideWell, Otsuka, Masimo and a collaboratory of strategic partners, entrepreneurs, industry executives and private investors.

StartUp Health Transformer Fund II will invest in and support companies around the world focused on health moonshots. Following the success of StartUp Health’s inaugural fund, which included 100 digital health companies, Fund II has already made multiple investments including Aver, Biome, CareDox, Cohero Health, Doctor.com, Human Longevity Inc., LifeDojo, Nightingale Health, and Zeel.

“We are proud to partner with StartUp Health and support its global mission to solve 10 of the world’s biggest health challenges,” said Fabrice Chouraqui, president of Novartis Pharmaceuticals USA. “I believe that together we can help empower health tech leaders to transform the future of healthcare and bring new innovations to millions of patients.”

“We’re taking on the challenge to reimagine medicine with data and digital,” said Bertrand Bodson, chief digital officer of Novartis. “Our partnership with StartUp Health is an exciting opportunity to accelerate our collaboration with the tech ecosystem and together create scalable digital solutions to real healthcare challenges.”

“StartUp Health has an unprecedented understanding of the impact health innovation is having on the entire industry, and people around the world,” said Giacomo Chiesi, Head of Global Corporate Development of Chiesi Group. “The entrepreneurs in StartUp Health’s portfolio, combined with our vision for the future of health and deep expertise in respiratory care, neonatology, special care and rare diseases, will fundamentally change the way we treat and care for patients.”

“Digital technologies offer unlimited possibilities, more than what we manage to exploit or imagine today,” said Umberto Stefani, Group CIO and Digital Transformation Officer, Chiesi Group. “Real time data are going to improve the way we cure patients and the amount of data available will ensure a huge advance to the development of new treatments. Collaboration is the key to accelerate this process.”

“From day one, we’ve had a synced vision with the leadership of Novartis, Ping An Group, Chiesi Group, GuideWell, Otsuka and our community of partners,” said Steven Krein, co-founder and CEO of StartUp Health. “We believe unique collaborations are required between entrepreneurs pushing innovation forward and the world’s industry leaders in order to solve today’s most complex healthcare challenges.”

StartUp Health has amassed the world’s largest portfolio of over 250 digital health companies from six continents and 21 countries, and has a global network of over 200,000 investors, customers and partners. StartUp Health is backed by leading health systems, payors and pharmaceutical companies committed to collaborating with entrepreneurs dedicated to transforming health by providing capital, expertise and commercialization opportunities to gain traction and scale. Entrepreneurs can learn more and apply to the StartUp Health Academy at http://www.startuphealth.com/apply.